Partners HealthCare (PHS) and Hewlett Packard (HP) established a strategic relationship in the area of personalized medicine. The partnership will focus primarily on developing the appropriate infrastructure to support the various information technology needs of the Partners HealthCare Center for Personalized Genetic Medicine (PCPGM). PHS goals are to integrate genomics and genetics into routine clinical practice to more effectively and comprehensively manage patient care. PHS recognized the need for significant IT infrastructure support to successfully execute this broad initiative. To that end, PHS and HP have established a partnership, whereby both organizations will combine their collective expertise, domain knowledge, experience, and technology to specifically deliver clinical genomics solutions.
Partners HealthCare and Affymetrix established a Translational Medicine Alliance focused on developing and validating microarray based clinical diagnostic tests based on the Affymetrix GeneChip platform. The impetus for this strategic relationship was to support research and molecular diagnostic laboratories such as the Partners HealthCare Center for Personalized Genetic Medicine's (PCPGM) Laboratory for Molecular Medicine (LMM) that share the vision of transitioning traditional testing to next generation platforms and technologies to drive efficiency and reduce costs. This multi-year, multi-agreement partnership has resulted in a number of valuable diagnostic chip-based tests for patients within and external to the Partners system.
For more information or questions, please contact Trung Do.